Volume 47, Issue 3, Pages e6 (September 2017)

Slides:



Advertisements
Similar presentations
Volume 28, Issue 5, Pages (May 2008)
Advertisements

Volume 24, Issue 5, Pages (May 2006)
Volume 42, Issue 1, Pages (January 2015)
Volume 15, Issue 2, Pages (February 2014)
Volume 43, Issue 6, Pages (December 2015)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 42, Issue 3, Pages (March 2015)
Volume 28, Issue 2, Pages (February 2008)
Volume 40, Issue 2, Pages (February 2014)
Volume 10, Issue 10, Pages (March 2015)
Volume 6, Issue 5, Pages (November 2009)
Volume 40, Issue 3, Pages (March 2014)
Volume 145, Issue 3, Pages e3 (September 2013)
Volume 38, Issue 4, Pages (April 2013)
Volume 22, Issue 1, Pages e4 (July 2017)
Volume 36, Issue 1, Pages (January 2012)
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
Volume 20, Issue 3, Pages (September 2016)
DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA  Jason W. Upton, William J.
Volume 68, Issue 2, Pages e5 (October 2017)
Volume 24, Issue 8, Pages (August 2018)
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Influenza Virus-Induced Glucocorticoids Compromise Innate Host Defense against a Secondary Bacterial Infection  Amanda M. Jamieson, Shuang Yu, Charles.
Volume 8, Issue 6, Pages (December 2010)
Volume 42, Issue 4, Pages (April 2015)
Double-Stranded RNA-Mediated TLR3 Activation Is Enhanced by CD14
Volume 29, Issue 4, Pages (October 2008)
Volume 36, Issue 4, Pages (April 2012)
Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin- Induced Autophagy Arrest  Ian G. Ganley, Pui-Mun Wong, Noor Gammoh, Xuejun.
Volume 32, Issue 2, Pages (February 2010)
Volume 47, Issue 4, Pages e3 (October 2017)
Volume 17, Issue 6, Pages (June 2015)
Volume 34, Issue 5, Pages (May 2011)
Extracellular M. tuberculosis DNA Targets Bacteria for Autophagy by Activating the Host DNA-Sensing Pathway  Robert O. Watson, Paolo S. Manzanillo, Jeffery S.
Volume 22, Issue 1, Pages e7 (July 2017)
Volume 23, Issue 2, Pages e7 (February 2018)
Volume 24, Issue 2, Pages (February 2006)
TET3 Inhibits Type I IFN Production Independent of DNA Demethylation
Volume 37, Issue 6, Pages (December 2012)
Volume 46, Issue 3, Pages (March 2017)
Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1  Cao-Qi Lei, Bo Zhong, Yu.
Volume 34, Issue 3, Pages (March 2011)
Antigen-Loading Compartments for Major Histocompatibility Complex Class II Molecules Continuously Receive Input from Autophagosomes  Dorothee Schmid,
Volume 25, Issue 5, Pages (November 2006)
Volume 23, Issue 2, Pages e7 (February 2018)
Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling
Oncogenic Ras-Induced Expression of Noxa and Beclin-1 Promotes Autophagic Cell Death and Limits Clonogenic Survival  Mohamed Elgendy, Clare Sheridan,
Volume 33, Issue 4, Pages (October 2010)
Volume 30, Issue 2, Pages (February 2009)
Volume 38, Issue 3, Pages (March 2013)
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Volume 12, Issue 6, Pages (December 2012)
Volume 34, Issue 2, Pages (February 2011)
Volume 36, Issue 4, Pages (April 2012)
Volume 4, Issue 6, Pages (December 2008)
Volume 5, Issue 5, Pages (May 2009)
Volume 21, Issue 6, Pages (November 2017)
Volume 44, Issue 5, Pages (May 2016)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Volume 30, Issue 6, Pages (June 2009)
Volume 13, Issue 2, Pages (October 2015)
Volume 40, Issue 4, Pages (April 2014)
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Volume 38, Issue 2, Pages (February 2013)
Volume 28, Issue 5, Pages (May 2008)
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Volume 156, Issue 4, Pages (February 2014)
Suman Paul, Anuj K. Kashyap, Wei Jia, You-Wen He, Brian C. Schaefer 
Volume 38, Issue 3, Pages (March 2013)
Presentation transcript:

Volume 47, Issue 3, Pages 498-509.e6 (September 2017) SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune Recognition  Tan A. Nguyen, Blake R.C. Smith, Michelle D. Tate, Gabrielle T. Belz, Marilou H. Barrios, Kirstin D. Elgass, Alexandra S. Weisman, Paul J. Baker, Simon P. Preston, Lachlan Whitehead, Alexandra Garnham, Rachel J. Lundie, Gordon K. Smyth, Marc Pellegrini, Meredith O’Keeffe, Ian P. Wicks, Seth L. Masters, Craig P. Hunter, Ken C. Pang  Immunity  Volume 47, Issue 3, Pages 498-509.e6 (September 2017) DOI: 10.1016/j.immuni.2017.08.007 Copyright © 2017 Elsevier Inc. Terms and Conditions

Immunity 2017 47, 498-509.e6DOI: (10.1016/j.immuni.2017.08.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 SIDT2 Localizes to Late Endosomes and Interacts with Internalized poly(I:C) (A) MEFs stably expressing SIDT2-mCherry were transfected with markers for (i) early endosomes (EEA1-GFP), (ii) late endosomes (RAB7-GFP), and (iii) lysosomes (LAMP1-YFP) and were imaged by confocal microscopy. Co-localization analysis of SIDT2-mCherry with endosomal markers was performed using FIJI software (see Results). Scale bar, 40 μm. (B) DC2.4 cells stably expressing SIDT2-mCherry were transfected with dsDNA-fluorescein or treated with poly(I:C)-fluorescein for 1 hr and imaged by confocal microscopy. (C and D) Assessment of SIDT2-mCherry interactions with poly(I:C)-fluorescein (C) and dsDNA-fluorescein (D) in DC2.4 cells via FRET FLIM. ∗∗p < 0.01. Data are plotted as ±SEM and are representative of three independent experiments. See also Movies S1, S2, S3, and S4. Immunity 2017 47, 498-509.e6DOI: (10.1016/j.immuni.2017.08.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Loss of SIDT2 Impairs Innate Immunity to EMCV Infection (A) Sidt2+/+ and Sidt2−/− mice (n = 6–9) were infected with 50 PFU EMCV i.p. and survival monitored for 8 days. (B and C) Sidt2+/+ and Sidt2−/− mice (n = 10–13) were sacrificed at 3 days p.i. and viral load was assessed in the heart (B) and PECs (C) by plaque assay. (D and E) Peritoneal lavage fluid (D) and serum (E) from Sidt2+/+ and Sidt2−/− mice (n = 10–13) were collected at day 3 p.i. and IFN-β was measured via ELISA. (F–H) Serum IL-6 (H), RANTES (F), and IL-12 p40 (G) from Sidt2+/+ and Sidt2−/− mice (n = 10–13) at 3 days p.i. were measured using Bioplex bead assay. Data are plotted as mean ± SEM. ∗p < 0.05, ∗∗∗p < 0.001, n.d., not detected. Immunity 2017 47, 498-509.e6DOI: (10.1016/j.immuni.2017.08.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 3 Loss of SIDT2 Impairs Innate Immunity to HSV-1 Infection (A) Vero cells were infected with 1 MOI GFP-tagged HSV-1 virus for 24 hr, stained with J2 anti-dsRNA antibody (red) and DAPI (blue), and imaged by confocal microscopy. In the absence of HSV-1 infection, no dsRNA was evident (top), whereas after HSV-1 challenge, dsRNA was readily observed in uninfected cells (bottom, arrows). Data are representative of three independent experiments. Scale bar, 20 μm. (B) Sidt2+/+ and Sidt2−/− MEFs were infected with 1 MOI mCherry-tagged HSV-1 virus for the indicated times and analyzed by flow cytometry. Data are representative of three independent experiments. Error bars represent mean ± SEM. (C) Cell culture supernatant from Sidt2+/+ and Sidt2−/− MEFs infected with 1 MOI mCherry-tagged HSV-1 was collected at 96 hr p.i. and IFN-β was measured via ELISA. (D) Sidt2+/+ and Sidt2−/− mice (n = 13–15) were infected with 1 × 107 PFU HSV-1 i.p. and survival monitored for 8 days. (E and F) Serum from Sidt2+/+ and Sidt2−/− mice (n = 10–13) was collected at 8 hr (E) and 16 hr (F) p.i. and serum IFN-β was measured via ELISA. (G and H) Serum IL-6 (H) and RANTES (G) from Sidt2+/+ and Sidt2−/− mice (n = 10–13) at 16 hr p.i. were measured using Bioplex bead assay. For (E)–(H), data are plotted as mean ± SEM. ∗p < 0.05, ∗∗∗p < 0.001, n.s., not significant. Data represent the pooled results from three independent experiments. See also Figure S3. Immunity 2017 47, 498-509.e6DOI: (10.1016/j.immuni.2017.08.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 4 Loss of SIDT2 Impairs Endosomal Escape of Internalized poly(I:C) (A and B) BMDCs from Sidt2+/+ and Sidt2−/− mice were treated with poly(I:C)-rhodamine (A) and 32P-labeled (B) 500 bp dsRNA for 60 min at either 4°C or 37°C, and internalization was assessed via flow cytometry or radioactivity measurement, respectively. Results are representative of at least two independent experiments. For (B), all treatments and measurements were made in triplicate, and data are plotted as mean ± SEM. (C and D) BMDCs from Sidt2+/+ and Sidt2−/− mice were treated with poly(I:C) for either 10 or 60 min, stained with J2 anti-dsRNA antibody (red) and DAPI (blue), and imaged by confocal microscopy (C). The proportion of each cell occupied by punctate dsRNA staining was quantified (D). (E and F) Sidt2+/+ and Sidt2−/− BMDCs were treated with poly(I:C) in association with the cationic polymer DEAE-dextran for 60 min. For (C) and (E), images are representative of at least three independent experiments. For (D) and (F), data are plotted as mean ± SEM and between 30 and 150 cells were assessed per time point. ∗p < 0.05. Scale bar, 10 μm. See also Figure S5. Immunity 2017 47, 498-509.e6DOI: (10.1016/j.immuni.2017.08.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 5 Overexpression of SIDT2 Enhances Endosomal Escape of poly(I:C) (A) Doxycycline-inducible SIDT2-mCherry DC2.4 cells were treated with poly(I:C)-fluorescein for 1 hr in the presence or absence of doxycycline and imaged by confocal microscopy. Scale bar, 10 μm. (B) The proportion of each cell occupied by punctate poly(I:C)-fluorescein staining was individually quantified for >60 cells across multiple fields of view and plotted as mean ± SEM. (C) Internalization of poly(I:C)-fluorescein by SIDT2-mCherry+ and SIDT2-mCherry− cells after 1 hr at either 4°C or 37°C was assessed via flow cytometry. Data are representative of three independent experiments. ∗∗∗∗p < 0.0001. See also Figure S5. Immunity 2017 47, 498-509.e6DOI: (10.1016/j.immuni.2017.08.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 6 SIDT2 Is Important for RLR- but Not TLR-Mediated IFN Production in Response to Extracellular dsRNA (A) Sidt2+/+ and Sidt2−/− mice were injected i.p. with 50 μg poly(I:C) per 25 g body weight (n = 7), and serum IFN-β measured at 3 hr via ELISA. (B) Sidt2+/+ and Sidt2−/− mice (n = 8) were injected i.p. with 300 μg poly(A:U) per 25 g body weight and serum IFN-β measured at 3 hr via ELISA. (C) Sidt2+/+ and Sidt2−/− mice (n = 8) were injected i.p. with 50 μg poly(I:C) per 25 g body weight and serum IFN-λ measured at 3 hr via ELISA (n = 8). Data are plotted as mean ± SEM. (D) BMDMs from Sidt2+/+ and Sidt2−/− were stimulated with 10 μg/mL poly(I:C) for the indicated times and pIRF3Ser386 and total IRF3 was assessed via immunoblotting. (E) Sidt2+/+ and Sidt2−/− MEFs were transfected with MAVS-YFP, treated with poly(I:C) for 1 hr, and MAVS aggregation assessed via confocal microscopy. Scale bar, 40 μm. (F) Individual cells (>150 per condition) were scored for the appearance of MAVS aggregates. Data are representative of three independent experiments and error bars are plotted as mean ± SEM. ∗p < 0.05; n.s., not significant; n.d., not detected. Immunity 2017 47, 498-509.e6DOI: (10.1016/j.immuni.2017.08.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 7 SIDT2 Is Required for RLR-Induced MAVS Activation in Bystander Cells during HSV-1 Infection (A) PECs from Sidt2+/+ and Sidt2−/− mice infected with 1 × 107 PFU at 16 hr p.i. were stained with J2 dsRNA antibody (red) and DAPI (blue) and imaged by confocal microscopy. Scale bar, 10 μm. (B) The proportion of each cell occupied by punctate dsRNA staining was quantified using FIJI software. (C) Sidt2+/+ and Sidt2−/− MEFs stably expressing MAVS-YFP were infected with 1 MOI HSV-1-mCherry for 48 hr and imaged via confocal microscopy to assess for MAVS aggregation (arrows) in uninfected, bystander cells. Scale bar, 80 μm. (D) Individual cells were segmented and HSV-1-mCherry-infected cells were excluded using FIJI software. Uninfected bystander cells (250 cells per condition) were scored for the appearance of MAVS aggregates. (E) Sidt2+/+ (Cas9 only), Sidt2−/− (Cas9 only), MAVS−/−, and Sidt2−/− MAVS−/− MEFs were infected with 1 MOI mCherry-tagged HSV-1, and IFN-β was measured in cell culture supernatant at 96 hr p.i. via ELISA. (F and G) IL-6 (F) and TNF-α (G) were measured in cell culture supernatant from shTLR3 and Sidt2−/− shTLR3 MEFs infected with 1 MOI mCherry-tagged HSV-1 96 hr p.i. Sidt2+/+ and Sidt2−/− MEFs transduced with retroviral vector lacking shRNA were used as controls. IFN-β, IL-6, and TNF-α in non-infected cells were below the limit of assay detection. Data are representative of results from two to three independent experiments and expressed as the mean ± SEM of triplicate wells. ∗p < 0.05, ∗∗p < 0.01, n.s., not significant. See also Figure S6. Immunity 2017 47, 498-509.e6DOI: (10.1016/j.immuni.2017.08.007) Copyright © 2017 Elsevier Inc. Terms and Conditions